Hoffman EP (2020) The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. FEBS J 287:3879–3887. https://doi.org/10.1111/febs.15466
Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251–267. https://doi.org/10.1016/S1474-4422(18)30024-3
Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533–2546. https://doi.org/10.1016/j.jacc.2016.02.081
Łoboda A, Dulak J (2020) Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacol Rep 72:1227–1263. https://doi.org/10.1007/s43440-020-00134-x
Kieny P, Chollet S, Delalande P et al (2013) Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. Ann Phys Rehabil Med 56:443–454. https://doi.org/10.1016/j.rehab.2013.06.002
Florczyk-Soluch U, Polak K, Dulak J (2021) The multifaceted view of heart problem in Duchenne muscular dystrophy. Cell Mol Life Sci 78:5447–5468. https://doi.org/10.1007/s00018-021-03862-2
Mercuri E, Bönnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394:2025–2038. https://doi.org/10.1016/S0140-6736(19)32910-1
Duan D, Goemans N, Takeda S et al (2021) Duchenne muscular dystrophy. Nat Rev Dis Prim 7:13. https://doi.org/10.1038/s41572-021-00248-3
Koenig M, Hoffman EP, Bertelson CJ et al (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517. https://doi.org/10.1016/0092-8674(87)90504-6
Gao QQ, McNally EM (2015) The dystrophin complex: structure, function, and implications for therapy. Compr Physiol 5:1223–1239. https://doi.org/10.1002/cphy.c140048
Sironi M, Cagliani R, Pozzoli U et al (2002) The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett 517:163–166. https://doi.org/10.1016/S0014-5793(02)02613-3
Ervasti JM (2007) Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772:108–117. https://doi.org/10.1016/j.bbadis.2006.05.010
Bagchi A (2015) Domain wise distribution of mutations in dystrophin protein and Duchenne muscular dystrophy. Gene Technol. https://doi.org/10.4172/2329-6682.1000128
Waldrop MA, Flanigan KM (2019) Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol 32:722–727. https://doi.org/10.1097/WCO.0000000000000739
Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta 1838:635–642. https://doi.org/10.1016/j.bbamem.2013.08.023
Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the duchenne muscular dystrophy locus. Cell 51:919–928. https://doi.org/10.1016/0092-8674(87)90579-4
Hathout Y, Brody E, Clemens PR et al (2015) Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 112:7153–7158. https://doi.org/10.1073/pnas.1507719112
Jackson MJ, Jones DA, Edwards RH (1985) Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy. Clin Chim Acta 147:215–221. https://doi.org/10.1016/0009-8981(85)90202-5
Robert V, Massimino ML, Tosello V et al (2001) Alteration in calcium handling at the subcellular level in mdx myotubes. J Biol Chem 276:4647–4651. https://doi.org/10.1074/jbc.M006337200
Law ML, Cohen H, Martin AA et al (2020) Dysregulation of calcium handling in duchenne muscular dystrophy-associated dilated cardiomyopathy: mechanisms and experimental therapeutic strategies. J Clin Med 9:520. https://doi.org/10.3390/jcm9020520
van Westering T, Betts C, Wood M (2015) Current understanding of molecular pathology and treatment of cardiomyopathy in Duchenne muscular dystrophy. Molecules 20:8823–8855. https://doi.org/10.3390/molecules20058823
Starosta A, Konieczny P (2021) Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci 78:4867–4891. https://doi.org/10.1007/s00018-021-03821-x
Tidball JG, Welc SS, Wehling-Henricks M (2018) Immunobiology of inherited muscular dystrophies. Compr Physiol 8:1313–1356. https://doi.org/10.1002/cphy.c170052
Rosenberg AS, Puig M, Nagaraju K et al (2015) Immune-mediated pathology in Duchenne muscular dystrophy. Science Transl Med 7:299rv4–299rv4. https://doi.org/10.1126/scitranslmed.aaa7322
Juban G, Saclier M, Yacoub-Youssef H et al (2018) AMPK activation regulates LTBP4-dependent TGF-β1 secretion by pro-inflammatory macrophages and controls fibrosis in Duchenne muscular dystrophy. Cell Rep 25:2163-2176.e6. https://doi.org/10.1016/j.celrep.2018.10.077
Mann CJ, Perdiguero E, Kharraz Y et al (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1:21. https://doi.org/10.1186/2044-5040-1-21
Magrath P, Maforo N, Renella P et al (2018) Cardiac MRI biomarkers for Duchenne muscular dystrophy. Biomark Med 12:1271–1289. https://doi.org/10.2217/bmm-2018-0125
Natarajan A, Lemos DR, Rossi FMV (2010) Fibro/adipogenic progenitors: a double-edged sword in skeletal muscle regeneration. Cell Cycle 9:2045–2046. https://doi.org/10.4161/cc.9.11.11854
Grounds MD, Terrill JR, Al-Mshhdani BA et al (2020) Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech 13:dmm043638. https://doi.org/10.1242/dmm.043638
von Maltzahn J, Jones AE, Parks RJ, Rudnicki MA (2013) Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc Natl Acad Sci USA 110:16474–16479. https://doi.org/10.1073/pnas.1307680110
Dumont NA, Wang YX, von Maltzahn J et al (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455–1463. https://doi.org/10.1038/nm.3990
Kottlors M, Kirschner J (2010) Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res 340:541–548. https://doi.org/10.1007/s00441-010-0976-6
Sacco A, Mourkioti F, Tran R et al (2010) Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 143:1059–1071. https://doi.org/10.1016/j.cell.2010.11.039
Bronisz-Budzyńska I, Chwalenia K, Mucha O et al (2019) miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skelet Muscle 9:22. https://doi.org/10.1186/s13395-019-0207-0
Bronisz-Budzyńska I, Kozakowska M, Podkalicka P et al (2020) The role of Nrf2 in acute and chronic muscle injury. Skelet Muscle 10:35. https://doi.org/10.1186/s13395-020-00255-0
Mucha O, Podkalicka P, Kaziród K et al (2021) Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy. Skelet Muscle 11:21. https://doi.org/10.1186/s13395-021-00276-3
De Palma C, Morisi F, Cheli S et al (2014) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 5:e1363. https://doi.org/10.1038/cddis.2014.312
Spitali P, Grumati P, Hiller M et al (2013) Autophagy is impaired in the tibialis anterior of dystrophin null mice. PLoS Curr 5:ecurrents.md.e1226cefa851a2f079bbc406c0a21e80. https://doi.org/10.1371/currents.md.e1226cefa851a2f079bbc406c0a21e80
Chang NC, Sincennes M-C, Chevalier FP et al (2018) The dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell commitment. Cell Stem Cell 22:755-768.e6. https://doi.org/10.1016/j.stem.2018.03.022
Shin H-JR, Kim H, Oh S et al (2016) AMPK–SKP2–CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534:553–557. https://doi.org/10.1038/nature18014
Sandri M, Coletto L, Grumati P, Bonaldo P (2013) Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J Cell Sci 126:5325–5333. https://doi.org/10.1242/jcs.114041
Mucha O, Kaziród K, Podkalicka P et al (2021) Dysregulated autophagy and mitophagy in a mouse model of duchenne muscular dystrophy remain unchanged following heme oxygenase-1 knockout. Int J Mol Sci 23:470. https://doi.org/10.3390/ijms23010470
Giménez-Xavier P, Francisco R, Platini F et al (2008) LC3-I conversion to LC3-II does not necessarily result in complete autophagy. Int J Mol Med 22:781–785
Moore TM, Lin AJ, Strumwasser AR et al (2020) Mitochondrial dysfunction is an early consequence of partial or complete dystrophin loss in mdx mice. Front Physiol 11:690. https://doi.org/10.3389/fphys.2020.00690
Vasconcellos LR, Siqueira MS, Moraes R et al (2018) Heme oxygenase-1 and autophagy linked for cytoprotection. Curr Pharm Des 24:2311–2316. https://doi.org/10.2174/1381612824666180727100909
Kang C, Badr MA, Kyrychenko V et al (2018) Deficit in PINK1/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovasc Res 114:90–102. https://doi.org/10.1093/cvr/cvx201
Luan P, D’Amico D, Andreux PA et al (2021) Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. Sci Transl Med 13:eabb0319. https://doi.org/10.1126/scitranslmed.abb0319
Kuno A, Hosoda R, Sebori R et al (2018) Resveratrol ameliorates mitophagy disturbance and improves cardiac pathophysiology of dystrophin-deficient mdx mice. Sci Rep 8:15555. https://doi.org/10.1038/s41598-018-33930-w
Pauly M, Daussin F, Burelle Y et al (2012) AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol 181:583–592. https://doi.org/10.1016/j.ajpath.2012.04.004
Podkalicka P, Mucha O, Dulak J, Loboda A (2019) Targeting angiogenesis in Duchenne muscular dystrophy. Cell Mol Life Sci 76:1507–1528. https://doi.org/10.1007/s00018-019-03006-7
Christov C, Chrétien F, Abou-Khalil R et al (2007) Muscle satellite cells and endothelial cells: close neighbors and privileged partners. MBoC 18:1397–1409. https://doi.org/10.1091/mbc.e06-08-0693
Harricane M-C, Febris E, Lees D et al (1994) Dystrophin does not influence regular cytoskeletal architecture but is required for contractile performance in smooth muscle aortic cells. Cell Biol Int 18:947–958. https://doi.org/10.1006/cbir.1994.1015
Loufrani L, Matrougui K, Gorny D et al (2001) Flow (shear stress)–induced endothelium-dependent dilation is altered in mice lacking the gene e
留言 (0)